Invivoscribe® is a global leader dedicated to Improving Lives with Precision Diagnostics®, advancing the quality of healthcare by providing innovative products and clinical services for oncology. Our Streamlined CDx® (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. With products manufactured in our state-of-the-art cGMP facility, we provide a comprehensive range of platform agnostic assays, reagents, controls and software for clonal gene rearrangements, translocations, gene mutation testing, and measurable residual disease (MRD). Invivoscribe’s products consistently surpass industry and regulatory standards and play a crucial role in identifying, stratifying and monitoring hematologic cancers, enabling scientific advancements and empowering clinicians to make informed treatment decisions. Our subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM®), offers extensive clinical diagnostic and biopharma services for the detection and monitoring of myelo- and lymphoproliferative disorders. The LabPMM network performs globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations, providing results that are critically important for patient care in the U.S., Europe, and Asia. Join us in our mission to revolutionize oncology diagnostics and improve patient outcomes worldwide. Visit our website to discover how Invivoscribe’s ecosystem is driving advancements in precision medicine.
View Top Employees from InvivoscribeWebsite | http://www.invivoscribe.com |
Revenue | $30 million |
Funding | $5 million |
Employees | 202 (202 on RocketReach) |
Founded | 1995 |
Address | 10222 Barnes Canyon Rd Building 1, San Diego, California 92121, US |
Phone | (858) 224-6600 |
Fax | (858) 224-6601 |
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, GMP manufacturing of RUO, Healthcare, Science and Engineering, ASR, Health Care, And Ce-Marked Products, Companion Diagnostics |
Web Rank | 7 Million |
Keywords | Precision Diagnostics, Flow Cytometry, Precision Medicine, Oncology |
Competitors | Enzo Biochem Inc, Molzym GmbH & Co. KG, Roka Bio, Werfen Autoimmunity, mdxhealth |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies |
Looking for a particular Invivoscribe employee's phone or email?
The Invivoscribe annual revenue was $30 million in 2024.
Bradley Patay is the Chief Medical Officer of Invivoscribe.
202 people are employed at Invivoscribe.
Invivoscribe is based in San Diego, California.
The NAICS codes for Invivoscribe are [5417, 54, 54171, 541, 541711].
The SIC codes for Invivoscribe are [28, 283].